You May Also Like

Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya
Cite
CITE Title : Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya Personal Author(s) : Iriemenam, Nnaemeka C;Shah, Monica;Gatei, Wangeci;van Eijk, Anna M;Ayisi, John;Kariuki, Simon;Vanden Eng, Jodi;Owino, Simon O;Lal, Ashima A;Omosun, Yusuf O;Otieno, Kephas;Desai, Meghna;ter Kuile, Feiko O;Nahlen, Bernard;Moore, Julie;Hamel, Mary J;Ouma, Peter;Slutsker, Laurence;Shi, Ya Ping; Published Date : July 04 2012 Source : Malar J. 2012; 11:134 URL : https://stacks.cdc.gov/view/cdc/89924
• File Format:
Copy Export
• RIS
[PDF - 1.30 MB]
Personal Author:
Iriemenam, Nnaemeka C ;
Shah, Monica
...
July 04 2012 | Malar J. 2012; 11:134
Description:
BackgroundResistance to sulphadoxine-pyrimethamine (SP) in Plasmodium falciparum parasites is associated with mutations in the dihydrofolate reductase...
File Type:
[PDF - 1.30 MB]
File Type:
[PDF - 1.30 MB]

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
Cite
CITE Title : Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017 Personal Author(s) : Rogier, Eric;Herman, Camelia;Huber, Curtis S.;Hamre, Karen E.S.;Pierre, Baby;Mace, Kimberly E.;Présumé, Jacquelin;Mondélus, Gina;Romilus, Ithamare;Elismé, Tamara;Eisele, Thomas P.;Druetz, Thomas;Existe, Alexandre;Boncy, Jacques;Lemoine, Jean F.;Udhayakumar, Venkatachalam;Chang, Michelle A.; Published Date : May 2020 Source : Emerg Infect Dis. 26(5):902-909 URL : https://stacks.cdc.gov/view/cdc/87651
• File Format:
Copy Export
• RIS
[PDF - 1.44 MB]
Personal Author:
Rogier, Eric ;
Herman, Camelia
...
May 2020 | Emerg Infect Dis. 26(5):902-909
Description:
Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (S...
File Type:
[PDF - 1.44 MB]
File Type:
[PDF - 1.44 MB]